| 1E8Y | A:726-883 | STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE |
| 1E8Z | A:726-883 | STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE |
| 1HE8 | A:726-883 | RAS G12V - PI 3-KINASE GAMMA COMPLEX |
| 2A4Z | A:726-883 | CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850 |
| 2A5U | A:726-883 | CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240 |
| 2CHW | A:726-883 | A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-39 |
| 2CHX | A:726-883 | A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90 |
| 2CHZ | A:726-883 | A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93 |
| 2RD0 | A:696-852 | STRUCTURE OF A HUMAN P110ALPHA/P85ALPHA COMPLEX |
| 2V4L | A:726-883 | COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA (P110 GAMMA) WITH PIK-284 |
| 3CSF | A:726-883 | CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2 |
| 3CST | A:726-883 | CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR E5E2 |
| 3DBS | A:726-883 | STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941 |
| 3DPD | A:726-883 | ACHIEVING MULTI-ISOFORM PI3K INHIBITION IN A SERIES OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINES |
| 3ENE | A:726-883 | COMPLEX OF PI3K GAMMA WITH AN INHIBITOR |
| 3IBE | A:726-883 | CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 KINASE GAMMA |
| 3L13 | A:726-883 | CRYSTAL STRUCTURES OF PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS |
| 3L16 | A:726-883 | DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT, SELECTIVE, AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER |
| 3L17 | A:726-883 | DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT, SELECTIVE, AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER |
)
)